Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × vatalanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Somatostatinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Insulinoma 2 Glucagonoma 2 Gliosarcoma 2 Gastrinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Islet Cell 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Vipoma 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

aldesleukin 38 Sunitinib 34 Cyclophosphamide 29 Nivolumab 27 pembrolizumab 25 Interferon-alpha 25 Everolimus 24 Sorafenib 20 fludarabine phosphate 19 Bevacizumab 19 Interleukin-2 17 Ipilimumab 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 Filgrastim 15 Radiotherapy 14 Axitinib 14 cabozantinib 13 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 10 Carboplatin 10 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 Ifosfamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303732 2016-03-03

PTK/RAD

Duke University

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡